See more : EXLA Resources Inc. (EXLA) Income Statement Analysis – Financial Results
Complete financial analysis of Amvis Holdings, Inc. (7071.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Amvis Holdings, Inc., a leading company in the Healthcare industry within the Healthcare sector.
You may be interested
- SciSparc Ltd. (SPRC) Income Statement Analysis – Financial Results
- Sorrento Therapeutics, Inc. (SRNEQ) Income Statement Analysis – Financial Results
- Sprint Bioscience AB (publ) (SPRINT.ST) Income Statement Analysis – Financial Results
- MarkLines Co., Ltd. (3901.T) Income Statement Analysis – Financial Results
- The Taiko Bank,Ltd. (8537.T) Income Statement Analysis – Financial Results
Amvis Holdings, Inc. (7071.T)
About Amvis Holdings, Inc.
Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 31.99B | 23.07B | 15.33B | 9.17B | 5.37B |
| Cost of Revenue | 18.71B | 13.39B | 9.03B | 5.42B | 3.22B |
| Gross Profit | 13.27B | 9.69B | 6.31B | 3.75B | 2.15B |
| Gross Profit Ratio | 41.49% | 41.99% | 41.12% | 40.88% | 40.01% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.20B | 3.21B | 2.27B | 1.70B | 1.24B |
| Other Expenses | 439.00M | 158.00M | 159.00M | 23.00M | 0.00 |
| Operating Expenses | 4.64B | 3.55B | 2.52B | 1.87B | 1.24B |
| Cost & Expenses | 23.36B | 16.94B | 11.55B | 7.30B | 4.46B |
| Interest Income | 0.00 | 0.00 | 0.00 | 658.00K | 662.00K |
| Interest Expense | 230.00M | 210.00M | 151.00M | 116.00M | 52.61M |
| Depreciation & Amortization | 1.20B | 834.00M | 547.00M | 281.00M | 186.00M |
| EBITDA | 10.39B | 7.10B | 4.48B | 2.17B | 1.10B |
| EBITDA Ratio | 32.47% | 30.79% | 29.20% | 23.71% | 20.41% |
| Operating Income | 8.63B | 6.13B | 3.78B | 1.88B | 910.00M |
| Operating Income Ratio | 26.98% | 26.58% | 24.68% | 20.45% | 16.95% |
| Total Other Income/Expenses | 312.00M | -72.00M | -5.00M | -99.00M | -52.74M |
| Income Before Tax | 8.94B | 6.06B | 3.78B | 1.78B | 857.00M |
| Income Before Tax Ratio | 27.96% | 26.27% | 24.64% | 19.37% | 15.96% |
| Income Tax Expense | 2.63B | 1.78B | 1.15B | 538.00M | 255.00M |
| Net Income | 6.31B | 4.28B | 2.63B | 1.24B | 602.00M |
| Net Income Ratio | 19.73% | 18.55% | 17.13% | 13.51% | 11.21% |
| EPS | 64.44 | 44.03 | 28.08 | 13.83 | 7.53 |
| EPS Diluted | 64.32 | 43.63 | 27.51 | 13.46 | 7.53 |
| Weighted Avg Shares Out | 97.92M | 97.20M | 46.79M | 89.59M | 80.00M |
| Weighted Avg Shares Out (Dil) | 98.10M | 98.07M | 95.49M | 92.07M | 80.00M |
No news found for: 7071.T
Source: https://incomestatements.info
Category: Stock Reports